Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      No change in audited results, evaluating bids: Fortis

      No change in audited results, evaluating bids: Fortis

      Ruby Khatun Khatun7 July 2018 3:57 PM IST
      New Delhi: Fortis Healthcare said there has been no change in its audited financial results compared to the unaudited numbers reported on June 27,...
      Apollo Hospitals acquire 50 percent stake in Medics Super Speciality Hospital for Rs 91 crore

      Apollo Hospitals acquire 50 percent stake in Medics Super Speciality Hospital for Rs 91 crore

      Ruby Khatun Khatun7 July 2018 1:53 PM IST
      New Delhi: Apollo Hospitals said it has acquired 50 percent stake in a Lucknow-based 330-bed super speciality hospital project for a consideration of...
      Biocon gets EU GMP certification for Bengaluru drug product facility

      Biocon gets EU GMP certification for Bengaluru drug product facility

      Ruby Khatun Khatun7 July 2018 10:30 AM IST
      New Delhi: Biotechnology major Biocon said it has received EU GMP certification for its sterile drug product manufacturing facility in Bengaluru.The...
      More pricing restrictions likely on hospitals: rating agency ICRA

      More pricing restrictions likely on hospitals: rating agency ICRA

      Ruby Khatun Khatun7 July 2018 10:15 AM IST
      MUMBAI: Regulatory overhang on the hospitals sector is likely to persist, with further pricing restriction expected on products and services in the...
      AHH raises 50 million dollar from Sheares Healthcare

      AHH raises 50 million dollar from Sheares Healthcare

      Ruby Khatun Khatun7 July 2018 10:00 AM IST
      Mumbai: Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Growth, the global middle market, and growth equity...
      Glenmark inks pact with Seqirus to commercialise Ryaltris in Australia, New Zealand

      Glenmark inks pact with Seqirus to commercialise Ryaltris in Australia, New Zealand

      Ruby Khatun Khatun7 July 2018 10:00 AM IST
      New Delhi: Glenmark Pharma said its subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Australia's Seqirus to...
      Philips launches India’s 1st Future Health Index

      Philips launches India’s 1st Future Health Index

      Ruby Khatun Khatun7 July 2018 9:45 AM IST
      New Delhi: Healthcare technology company Royal Philips launched its first edition of India’s Future Health Index (FHI), a research-based platform.The...
      Drugmakers try evasion, tougher negotiations to fight new US insurer tactic

      Drugmakers try evasion, tougher negotiations to fight new US insurer tactic

      Ruby Khatun Khatun7 July 2018 9:30 AM IST
      NEW YORK: In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from...
      Deferred: Ban on manufacturing of oxytocin formulations by pvt firms

      Deferred: Ban on manufacturing of oxytocin formulations by pvt firms

      Ruby Khatun Khatun6 July 2018 2:55 PM IST
      New Delhi: The scheduled ban on the manufacture of Oxytocin formulations by the private sector, which was to come into effect from July 1, has been...
      Unichem Labs gets USFDA nod for asthma drug

      Unichem Labs gets USFDA nod for asthma drug

      Ruby Khatun Khatun6 July 2018 10:30 AM IST
      New Delhi: Drug firm Unichem Laboratories said it has received final approval from the US health regulator for its Montelukast chewable tablets used...
      ITC planning to enter in Healthcare sector: Sanjiv Puri

      ITC planning to enter in Healthcare sector: Sanjiv Puri

      Ruby Khatun Khatun6 July 2018 10:15 AM IST
      Hyderabad: ITC Limited, a multi-business conglomerate is planning to enter in the healthcare sector, ITC Limited Managing Director Sanjiv Puri said on...
      Biogen, Eisais Alzheimers drug succeeds in mid-stage trial, shares soar

      Biogen, Eisai's Alzheimer's drug succeeds in mid-stage trial, shares soar

      Ruby Khatun Khatun6 July 2018 10:00 AM IST
      Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok